Maryland HB 382: Maryland Department of Health and Prescription Drug Affordability Board - Managed Care Organizations and Prescription Drug Claims - Study

Status: Approved by the Governor - Chapter 217 (as of 2023-04-24)

State: Maryland · Session: 2023 · Bill: HB 382

Sponsors: Alston, Bagnall, Bhandari, Chisholm, Cullison, Guzzone, Hill, Hutchinson, Kaiser, Kerr, Kipke, Lopez, M. Morgan, Martinez, Pena-Melnyk, R. Lewis, Reilly, Rosenberg, S. Johnson, Szeliga, Taveras, White, Woods

View Maryland HB 382 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.